InvestorsHub Logo

DonDonDonDon

04/26/21 1:07 PM

#161764 RE: Bill_ENG #161762

The difference in the age stratification that ended up happening meant that the Placebo arm without any other considerations was given a headstart due to the naturally lower mortality rate of younger patients vs older patients. The intended 2:1 ratio of under 65 ended up as 3:1.


What is the difference in the age stratification of the 62 critical patients?

justdafactss

04/26/21 1:09 PM

#161765 RE: Bill_ENG #161762

Yes it was definitely a failure.

As yourselves this- Would shareholders be whining begging and shifting blame if leronlimab had reached its endpoints with flying colors?